share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Jones-Burton Charlotte

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Jones-Burton Charlotte

bluebird bio | 4:持股變動聲明-董事 Jones-Burton Charlotte
美股SEC公告 ·  2024/11/09 05:17

Moomoo AI 已提取核心訊息

Charlotte Jones-Burton, associated with bluebird bio, Inc. [BLUE], was granted 24,900 shares of common stock on November 6, 2024. The transaction, which was completed on the same day, was a non-monetary grant, as the shares were acquired at a price of $0.00. Following this transaction, Jones-Burton's direct holdings in the company increased to a total of 43,462 shares of common stock.
Charlotte Jones-Burton, associated with bluebird bio, Inc. [BLUE], was granted 24,900 shares of common stock on November 6, 2024. The transaction, which was completed on the same day, was a non-monetary grant, as the shares were acquired at a price of $0.00. Following this transaction, Jones-Burton's direct holdings in the company increased to a total of 43,462 shares of common stock.
Charlotte Jones-Burton是與bluebird bio, Inc. [BLUE]有關聯的,於2024年11月6日被授予24,900股普通股。該交易於同一天完成,屬於非貨幣性授予,因爲這些股票的價格爲$0.00。在此次交易之後,Jones-Burton在公司的直接持股增至總共43,462股普通股。
Charlotte Jones-Burton是與bluebird bio, Inc. [BLUE]有關聯的,於2024年11月6日被授予24,900股普通股。該交易於同一天完成,屬於非貨幣性授予,因爲這些股票的價格爲$0.00。在此次交易之後,Jones-Burton在公司的直接持股增至總共43,462股普通股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息